Acadia Pharmaceuticals (ACAD) Capital Expenditures (QoQ) (2012 - 2026)
Acadia Pharmaceuticals (ACAD) Capital Expenditures (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.14% |
| Dec 31, 2025 | 932.22% |
| Sep 30, 2025 | 30.64% |
| Dec 31, 2024 | 547.14% |
| Jun 30, 2021 | -95.82% |
| Mar 31, 2021 | -46.17% |
| Dec 31, 2020 | 16.15% |
| Sep 30, 2020 | -41.32% |
| Jun 30, 2020 | 214.03% |
| Mar 31, 2020 | 351.21% |
| Dec 31, 2019 | 158.75% |
| Sep 30, 2019 | 300.00% |
| Jun 30, 2019 | -97.57% |
| Mar 31, 2019 | 56.27% |
| Dec 31, 2018 | -48.18% |
| Sep 30, 2018 | 782.61% |
| Jun 30, 2018 | -74.33% |
| Mar 31, 2018 | 6,300.00% |
| Dec 31, 2017 | -87.50% |
| Sep 30, 2017 | -78.79% |